Frontlight ResearchEarly access
Familial hypercholesterolaemia trials in South Korea
4 of 7 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in South KoreaA Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin, and Placebo on LDL-C in LLT-naïve Patients
- Where
- Daegu, Seoul, Wŏnju
- Age
- 18 years and over
- People
- 204 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07930507 - No phaseNot yet taking people in South KoreaGuideline Oriented Approach To Lipid Lowering In Asia-Pacific
- Where
- Pyeongchon, Seoul
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Stephen Nicholls
See details and how to joinNCT05325034 - No phaseTaking peopleModerate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
- Where
- Seoul
- Age
- 19 years to 85 years
- People
- 1,952
- Run by
- Yonsei University
See details and how to joinNCT07524101 - Phase 3Enrolling by invitationTo Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia
- Where
- Seoul
- Age
- 19 years and over
- People
- 125
- Run by
- Hyundai Pharm
See details and how to joinNCT06646354